PRL and breast cancer: The implications of sexual dysfunction for treatment compliance and the prevention of relapse, together with the potential link between primary and secondary prolactinaemia and breast cancer and/or decreased bone mineral density [29] makes serum prolactin an important endpoint in the assessment of antipsychotic therapy.